Abstract
Purpose
We aimed evaluate clinical problems in the diagnosis and treatment of hospital-associated pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA-HAP) at a single institute.
Methods
Forty-two patients, diagnosed with MRSA-HAP by a primary physician, who had received antimicrobial therapy during a period of 18 consecutive months at University Hospital, Kyoto Prefectural University of Medicine, were enrolled in the study. For comparison, 36 patients in whom MRSA was recovered from the respiratory tract during the same period, but who were not treated for pneumonia, were chosen as untreated controls. A clinical pulmonary infection score (CPIS) was calculated retrospectively by a chart review. The CPIS was calculated on day 1 and day 3. In the treated group, serum concentrations of each therapeutic drug used were also evaluated.
Results
The day-1 and day-3 CPIS showed a similar trend in the two at groups, at 2.5 ± 1.8 and 3.9 ±1.9, respectively, in the treated group and 2.9 ± 1.9 and 3.8 ± 1.6 in the control group. Only two (5%) patients in the treated group showed a CPIS of more than 6 on day 1. Only five patients (12%) in the treated group were treated with antimicrobials at appropriate target therapeutic serum concentrations. The 30-day mortality in the treated group was significantly higher than that in the control group, even when we matched the baseline morbidity of patients using the Acute Physiology and Chronic Health Evaluation II (APACHE II) score.
Conclusion
This study revealed the clinical problems in our setting, in that MRSA colonization in the respiratory tract was frequently treated as pneumonia, and antimicrobial dosage was frequently insufficient. Prudent differential diagnosis of and treatment for HAP due to MRSA infection should be considered.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lode H, Raffenberg M, Erbes R, Geerdes-Fenge H, Mauch H. Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and prevention. Curr Opin Infect Dis. 2000;13:377–384.
Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, CDC; Healthcare Infection Control Practices Advisory Committee. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2003;53(RR-3):1–36.
Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27:887–892.
Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med. 2001;29:N64–68.
Fabregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax. 1999;54:867–873.
Ho PL; For the Hong Kong Intensive Care Unit Antimicrobial Resistance Study (HK-ICARE) Group. Carriage of methicillinresistant Staphylococcus aureus, ceftazidime-resistant Gramnegative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med. 2003;31:1175–1182.
Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–1129.
Iwamoto T, Kagawa Y, Kojima M. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol Pharm Bull. 2003;26:876–879.
Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–698.
Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505–511.
Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150:1545–1549.
El-Solh AA, Aquilina AT, Dhillon RS, Ramadan F, Nowak P. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med. 2002;166:1038–1043.
Johanson WG Jr, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701–706.
Niederman MS. Gram-negative colonization of the respiratory tract: pathogenesis and clinical consequences. Semin Respir Infect. 1990;5:173–184.
Dennesen PJ, van der Ven AJ, Kessels AG, Ramsay G, Bonten MJ. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med. 2001;163:1371–1375.
Cruciani M, Gatti G, Lazzarini L, Furlan G, Broccali G, Malena M, Franchini C, Concia E. Penetration of vancomycin into human lung tissue. J Antimicrob Chemother. 1996;38:865–869.
Begg EJ, Barclay ML, Kirkpatrick CJ. The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol. 1999;47:23–30.
Torres A, el-Ebiary M. Invasive diagnostic techniques for pneumonia: protected specimen brush, bronchoalveolar lavage, and lung biopsy methods. Infect Dis Clin North Am. 1998;12:701–722.
Nseir S, Di Pompeo C, Pronnier P, Beague S, Onimus T. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J. 2002;20:1483–1489.
Author information
Authors and Affiliations
Additional information
This study was performed at Kyoto Prefectural University Hospital.
About this article
Cite this article
Sakaguchi, M., Shime, N., Fujita, N. et al. Current problems in the diagnosis and treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia. J Anesth 22, 125–130 (2008). https://doi.org/10.1007/s00540-007-0600-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-007-0600-4